Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...

Investors and other persons interested in learning more about the virtual investor presentation can find information and registration details at the following link: About Gevo Gevo is a ...

Tobacco firm Philip Morris’ 2025 earnings guidance easily topped expectations, overshadowing the fourth-quarter report.

Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price ...

Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its price objective increased by research analysts at DA Davidson from $47.00 to $105.00 in a note issued to investors on Tuesday,Benzinga ...

Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an ...

It's only February, but GE Vernova 's ( GEV 1.75%) stock has already had an exciting year. The share rose by 13.4% in January ...

Shares of GE Vernova Inc. GEV advanced 3.20% to $367.93 Wednesday, on what proved to be an all-around positive trading ...

GE Vernova Inc. GEV recently revealed its plans to invest almost $600 million in its U.S. factories and facilities over the next two years to address rising global energy demand, which is expected to ...